Severe autoimmune hepatitis in a chronic myeloid leukemia patient treated with interferon alpha and with complete genetic response

American Journal of Hematology

Volumn 59, Issue 1, 1998, Pages 95-97

  Steegmann, Juan Luis ^a   Requena, María José ^a   García Buey, María Luisa ^a   Granados, Enrique ^a   Romero, Rafael ^b   Fernández Rañada, Jose María ^a   Moreno, Ricardo ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^b HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

Author keywords

Autoantibodies; Autoimmune hepatitis; Chronic myeloid leukemia; Interferon alpha

Indexed keywords

ALPHA2A INTERFERON; BUSULFAN;

ADULT; APLASTIC ANEMIA; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE HEPATITIS; CASE REPORT; CHRONIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CYTOGENETICS; DRUG INDUCED DISEASE; FEMALE; HEPATITIS; HUMAN; HYPOTHYROIDISM; PRIORITY JOURNAL;

AUTOIMMUNE DISEASES; BLOTTING, SOUTHERN; FEMALE; HEPATITIS; HUMANS; INTERFERON-ALPHA; KARYOTYPING; LEUKEMIA, MYELOID, CHRONIC; MIDDLE AGED; SEVERITY OF ILLNESS INDEX;

EID: 0031857163     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199809)59:1<95::AID-AJH19>3.0.CO;2-0     Document Type: Article

References (9)

1. Kälkner M, Hagberg H, Karlsson-Parra A: Autoantibody occurrence in hairy-cell leukemia during prolonged interferon treatment. Eur J Haematol 45:233, 1990.
2. De Maeyer E, De Maeyer-Guignard J: The presence and possible pathogenic role of interferonsin disease. In De Maeyer E, eds. Interferons and Other Regulatory Cytokines. New York: John Wiley & Sons, 1988.
3. Johnsonn P, McFarlane I: Meeting report: International Autoimmune Hepatitis Group. Hepatology 18:998, 1993.
4. Reiffers J, Taylor K, Gluckman E, Gorin N, Carella A, Destrée D, Gautier L: Ph negative blood progenitors cells can be successfully collected with lenograstim in patients with chronic myeloid leukemia good responsers to alpha-interferon. Bone Marrow Transplant 17 (Suppl1):S4, 1996.
5. Krawitt EL: Medical progress: Autoimmune hepatitis. N Engl J Med 334:897, 1996.
6. Sacchi S, Kantarjian H, O'Brien S, Cohen PR, Pierce S, Talpaz M: Immune mediated and unusual complications during IFN alfa therapy in chronic myelogenous leukemia. J Clin Oncol 13:2401, 1995.
7. Steegmann JL, Pinilla I, Requena MJ, de la Cámara R, Granados E, Fernández Villalta MJ, Fernández-Rañada JM: The direct antiglobulin test is frequently positive in chronic myeloid leukemia patients treated with interferon-α. Transfusion 37:446, 1997.
8. García-Buey R, García-Monzón C, Rodriguez S, Borque MJ, Garcia Sanchez A, Iglesias R, De Castro M, Mateos FG, Vicario JL, Balas A, Moreno R: Latent autoimmune hepatitis triggered during interferon therapy in patients with chronic hepatitis C. Gastroenterology 108: 1770, 1995.
9. Talpaz M, Estrov Z, Kantarjian H, Ku S, Foteh A, Kurzrock R: Persistence of dormant leukemic progenitors during interferon-induced remission in chronic myelogenous leukemia. Analysis by polymerase chain reaction of individual colonies. J Clin Invest 94:1383, 1994.